Find a Tender
complete
Official procurement procedure
NHS Diabetic Eye Screening Programme London Region
Health and social work services
Published value
Not published
Submission deadline Not published
Lots published5
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Diabetic Eye Screening Programme London Region". Published status: complete. Published value: Value not published. 5 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
4.2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 62 active published awards; 61 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published15 Oct 2024, 15:14 BST | Last source update15 Oct 2024, 15:14 BST | Recurring procurementNot published |
ClassificationHealth and social work services | ||
Delivery area | ||
OCIDocds-h6vhtk-03e155 | ||
What is being bought
The award notice concerns the procurement of 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).
The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.
The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
•Identifies the eligible population and ensures effective delivery with maximum coverage.
•Is safe, effective, high quality, externally and independently monitored, and quality assured.
•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.
•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.
•Has audit embedded in the service.
•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are 3 key elements of service delivery, namely:
•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.
•Digital surveillance where individuals need more frequent screening.
•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance.
The Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.
The 7-year estimated contract values, based on predicted activity levels, are:
Lot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336
Please note, the full indicative contract values per each financial year can be found in the tender documentation.
What changed
From the official release history
- Status changed to complete
15 Oct 2024, 15:14 BST - Official notice release published
15 Oct 2024, 15:14 BST - Official notice release published
14 Sept 2023, 16:33 BST - Status changed to published status
30 Aug 2023, 10:00 BST - Official notice release published
30 Aug 2023, 10:00 BST - Submission deadline changed to published date
30 Aug 2023, 10:00 BST - Status changed to active
12 Jul 2023, 17:07 BST - Official notice release published
12 Jul 2023, 17:07 BST - Submission deadline changed to 30 Aug 2023, 12:00 BST
12 Jul 2023, 17:07 BST - Buyer information updated
12 Jul 2023, 17:07 BST
Lots and requirements (5)
Published by the contracting authority
- Lot 1 · #1North West LondonStatus not publishedPublished valueNot publishedNHS England (London Region) (hereafter referred to as "the Authority")was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2North Central LondonStatus not publishedPublished valueNot publishedNHS England (London Region) (hereafter referred to as "the Authority") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3North East LondonStatus not publishedPublished valueNot publishedNHS England (London Region) (hereafter referred to as "the Authority") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4South East LondonStatus not publishedPublished valueNot publishedNHS England (London Region) (hereafter referred to as "the Authority") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #5South West LondonStatus not publishedPublished valueNot publishedNHS England (London Region) (hereafter referred to as "the Authority") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
15 Oct 2024, 15:14 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed Not published · £32,719,770 - Contract active
Signed Not published · £18,384,296 - Contract active
Signed Not published · £28,017,330 - Contract active
Signed Not published · £20,912,350 - Contract active
Signed Not published · £17,124,945
Commercial outcome and competition
Awards InHealth Intelligence Limited Not published · Not published · active North Middlesex University Hospital NHS Trust Not published · Not published · active Homerton University Hospital Foundation Trust Not published · Not published · active Guy's and St Thomas' NHS Foundation Trust Not published · Not published · active NEC Software Solutions UK Limited Not published · Not published · active |
Contracts North West London £32,719,770 · signed Not published · active North Central London £18,384,296 · signed Not published · active North East London £28,017,330 · signed Not published · active South East London £20,912,350 · signed Not published · active South West London £17,124,945 · signed Not published · active |
Bid statistics bids: 2 (lot 1) bids: 2 (lot 2) bids: 2 (lot 3) bids: 2 (lot 4) bids: 3 (lot 5) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-NHS-Y56Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published